PMC Articles for PubChem Compound (Select 90311989) - PMC

Links from PubChem Compound

Items: 1 to 20 of 80

<< First< Prev

Page of 4

Select item 112383601.

Real world community-based HIV Rapid Start Antiretroviral with B/F/TAF versus prior models of antiretroviral therapy start – the RoCHaCHa study, a pilot study

William Valenti, Jacob Scutaru, Michael Mancenido, Ashley Zuppelli, Alexandra Danforth, Roberto Corales, Shealynn Hilliard

AIDS Res Ther. 2024; 21: 45. Published online 2024 Jul 10. doi: 10.1186/s12981-024-00631-6

PMCID:: PMC11238360

Abstract Article PDF–1.0M

Select item 111847032.

Patient-reported outcomes and experiences of migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite treatment dispensation: the ‘ASAP’ study

Anish K. Arora, Serge Vicente, Kim Engler, David Lessard, Edmundo Huerta, Joel Ishak, Nadine Kronfli, Jean-Pierre Routy, Joseph Cox, Benoit Lemire, Marina Klein, Alexandra de Pokomandy, Lina Del Balso, Giada Sebastiani, Isabelle Vedel, Amélie Quesnel-Vallée, Bertrand Lebouché, ASAP Migrant Advisory Committee

AIDS Res Ther. 2024; 21: 40. Published online 2024 Jun 18. doi: 10.1186/s12981-024-00632-5

PMCID:: PMC11184703

Abstract Article PDF–1.0M

Select item 111577403.

Safety and adherence of bictegravir/emtricitabine/tenofovir alafenamide for HIV post-exposure prophylaxis among adults in Guiyang China: a prospective cohort study

Lin Gan, Xiaoxin Xie, Yanhua Fu, Xiaoyan Yang, Shujing Ma, Linghong Kong, Chunli Song, Yebing Song, Tingting Ren, Hai Long

BMC Infect Dis. 2024; 24: 565. Published online 2024 Jun 6. doi: 10.1186/s12879-024-09407-9

PMCID:: PMC11157740

Abstract Article PDF–1.2M

Select item 111204334.

Effects of Antiretroviral Treatment on Central and Peripheral Immune Response in Mice with EcoHIV Infection

Qiaowei Xie, Mark D. Namba, Lauren A. Buck, Kyewon Park, Joshua G. Jackson, Jacqueline M. Barker

Cells. 2024 May; 13(10): 882. Published online 2024 May 20. doi: 10.3390/cells13100882

PMCID:: PMC11120433

Abstract Article PDF–2.4M

Select item 110649185.

Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy

Chloe Orkin, Andrea Antinori, Jürgen K. Rockstroh, Santiago Moreno-Guillén, Claudia T. Martorell, Jean-Michel Molina, Adriano Lazzarin, Franco Maggiolo, Yazdan Yazdanpanah, Kristen Andreatta, Hailin Huang, Jason T. Hindman, Hal Martin, Anton Pozniak

AIDS. 2024 Jun 1; 38(7): 983–991. Published online 2024 Feb 21. doi: 10.1097/QAD.0000000000003865

PMCID:: PMC11064918

Abstract Article PDF–318K

Select item 110299426.

Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV from the Canadian cohort of the observational BICSTaR study

Alexander Wong, Jason Brunetta, Joss De Wet, Ken Logue, Hugues Loemba, Taban Saifi, Dylana Mumm, Andrea Marongiu, Rebecca Harrison, David Thorpe, Benoit Trottier

Medicine (Baltimore) 2024 Apr 19; 103(16): e37785. Published online 2024 Apr 19. doi: 10.1097/MD.0000000000037785

PMCID:: PMC11029942

Abstract Article PDF–611K

Select item 107157037.

A study of the pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed pregnant women with HIV

Haeyoung Zhang, Jason T. Hindman, Ludwig Lin, Maggie Davis, Justin Shang, Deqing Xiao, Anchalee Avihingsanon, Priyanka Arora, Ramesh Palaparthy, Sandhya Girish, Dhananjay D. Marathe

AIDS. 2024 Jan 1; 38(1): F1–F9. Published online 2023 Nov 22. doi: 10.1097/QAD.0000000000003783

PMCID:: PMC10715703

Abstract Article PDF–227K

Select item 107149858.

Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice

Diana Canetti, Laura Galli, Riccardo Lolatto, Silvia Nozza, Vincenzo Spagnuolo, Camilla Muccini, Benedetta Trentacapilli, Elena Bruzzesi, Martina Ranzenigo, Matteo Chiurlo, Antonella Castagna, Nicola Gianotti

Drug Des Devel Ther. 2023; 17: 3697–3706. Published online 2023 Dec 8. doi: 10.2147/DDDT.S437043

PMCID:: PMC10714985

Abstract Article PDF–2.3M

Select item 106842519.

Efficacy and safety profiles of dolutegravir plus lamivudine vs. bictegravir/emtricitabine/tenofovir alafenamide in therapy-naïve adults with HIV-1

Yinghua Wei, Jin Li, Ruhong Xu, Li Wen, Yiming Deng, Lixia He, Huijun Zhong, Yanhao Wang

Chin Med J (Engl) 2023 Nov 20; 136(22): 2677–2685. Published online 2023 Nov 2. doi: 10.1097/CM9.0000000000002907

PMCID:: PMC10684251

Abstract Article PDF–664K

Select item 1068416010.

Outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus efavirenz-based regimens in central China: a real-world assessment

Yongquan Peng, Xujian Cao, Yating Wang, Weiwei Yu, Ziwei Zeng, Min Wang

Chin Med J (Engl) 2023 Nov 20; 136(22): 2738–2740. Published online 2023 Oct 25. doi: 10.1097/CM9.0000000000002888

PMCID:: PMC10684160

Article PDF–177K

Select item 1054094411.

Effectiveness, durability and safety of dolutegravir and lamivudine versus bictegravir, emtricitabine and tenofovir alafenamide in a real-world cohort of HIV-infected adults

Inés Mendoza, Alicia Lázaro, Alfredo Espinosa, Lorenzo Sánchez, Ana María Horta, Miguel Torralba

PLoS One. 2023; 18(9): e0291480. Published online 2023 Sep 29. doi: 10.1371/journal.pone.0291480

PMCID:: PMC10540944

Abstract Article PDF–1.2M

Select item 1054088712.

Trastornos en la calidad del sueño asociados a los inhibidores de la integrasa en el tratamiento del VIH

Manuel Vélez-Díaz-Pallarés, Beatriz Esteban-Cartelle, Teresa Gramage-Caro, Beatriz Montero-Llorente, María de los Ángeles Parro-Martín, Miguel Ángel Rodríguez-Sagrado, Ana María Álvarez-Díaz

Rev Esp Salud Publica. 2023 Jan-Dec; 97: e202306052. Spanish. Published online 2023 Jun 19.

PMCID:: PMC10540887

Abstract Article PDF–656K

Select item 1046141613.

Clinical efficacy, safety, and subjective experience based on ePRO in HIV‐infected individuals administered Bictegravir/Emtricitabine/Tenofovir Alafenamide in southwest China

Linghong Kong, Xiaoxin Xie, Yanhua Fu, Lin Gan, Xiaoyan Yang, Shujing Ma, Hai Long

Immun Inflamm Dis. 2023 Aug; 11(8): e974. Published online 2023 Aug 28. doi: 10.1002/iid3.974

PMCID:: PMC10461416

Abstract Article PDF–1.2M

Select item 1045938014.

Prevalence and Risk Factors for Poor Sleep Quality in People Living with HIV: Preliminary Observations from an HIV Outpatient Clinic

Giuseppe Bruno, Massimo Giotta, Serena Perelli, Vito Spada, Maria Antonietta Purgatorio, Nicola Bartolomeo, Giovanni Battista Buccoliero

Viruses. 2023 Aug; 15(8): 1715. Published online 2023 Aug 10. doi: 10.3390/v15081715

PMCID:: PMC10459380

Abstract Article PDF–265K

Select item 1045895015.

Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study

Monica Basso, Giuliana Battagin, Stefano Nicolè, Maria Cristina Rossi, Francesco Colombo, Nicole Pirola, Stefano Baratti, Silvia Storato, Federico Giovagnorio, Vincenzo Malagnino, Grazia Alessio, Antonio Vinci, Massimo Maurici, Loredana Sarmati, Saverio Giuseppe Parisi

Viruses. 2023 Aug; 15(8): 1727. Published online 2023 Aug 12. doi: 10.3390/v15081727

PMCID:: PMC10458950

Abstract Article PDF–1.8M

Select item 1041174116.

Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir

Nicola Squillace, Elena Ricci, Paolo Maggi, Lucia Taramasso, Barbara Menzaghi, Giuseppe Vittorio De Socio, Stefania Piconi, Benedetto Maurizio Celesia, Giancarlo Orofino, Eleonora Sarchi, Giovanni Francesco Pellicanò, Filomena Simeone, Laura Valsecchi, Alessandra Bandera, Giovanni Cenderello, Letizia Attala, Goffredo Angioni, Katia Falasca, Antonio Cascio, Olivia Bargiacchi, Antonio Di Biagio, Paolo Bonfanti, for the CISAI Study Group

PLoS One. 2023; 18(8): e0289132. Published online 2023 Aug 9. doi: 10.1371/journal.pone.0289132

PMCID:: PMC10411741

Abstract Article PDF–539K

Select item 1039850617.

Investigation of antiviral substances in Covid 19 by Molecular Docking: In Silico Study

Erkan Oner, Ilter Demirhan, Meral Miraloglu, Serap Yalin, Ergul Belge Kurutas

Afr Health Sci. 2023 Mar; 23(1): 23–36. doi: 10.4314/ahs.v23i1.4

PMCID:: PMC10398506

Abstract Article PDF–586K

Select item 1038844818.

Increased human immunodeficiency virus viral load with cerebral infarction due to varicella zoster virus vasculopathy on treatment with bictegravir/emtricitabine/tenofovir alafenamide suspension: a case report and literature review

Kazuhiro Ishikawa, Fujimi Kawai, Nobuyoshi Mori

AIDS Res Ther. 2023; 20: 53. Published online 2023 Jul 30. doi: 10.1186/s12981-023-00547-7

PMCID:: PMC10388448

Abstract Article PDF–1.2M

Select item 1030252719.

Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort

Alessandro Lazzaro, Diana Bianchini, Elio Gentilini Cacciola, Ivano Mezzaroma, Mario Falciano, Carolina Andreoni, Caterina Fimiani, Letizia Santinelli, Luca Maddaloni, Ginevra Bugani, Giancarlo Ceccarelli, Claudio Maria Mastroianni, Gabriella d’Ettorre

Viruses. 2023 Jun; 15(6): 1222. Published online 2023 May 23. doi: 10.3390/v15061222

PMCID:: PMC10302527

Abstract Article PDF–2.3M

Select item 1026686520.

CROI 2023: Advances in Antiviral Therapy in HIV and Viral Hepatitis

Shauna H. Gunaratne, Barbara S. Taylor, Timothy J. Wilkin, Hong-Van Tieu

Top Antivir Med. 2023 May; 31(3): 445–467. Published online 2023 May 1.

PMCID:: PMC10266865

Abstract Article PDF–560K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from PubChem Compound

Items: 1 to 20 of 80

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity